Disc Medicine, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 56.0% | 56.0% | -38.9% |
| FY2022 | -26.5% | -26.5% | -23.4% |
| FY2023 | -22.1% | -22.1% | -20.8% |
| FY2024 | -24.7% | -23.2% | -22.0% |
| FY2025 | -28.7% | -27.6% | -26.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 56.0% | 56.0% | -38.9% |
| FY2022 | -26.5% | -26.5% | -23.4% |
| FY2023 | -22.1% | -22.1% | -20.8% |
| FY2024 | -24.7% | -23.2% | -22.0% |
| FY2025 | -28.7% | -27.6% | -26.3% |